ResMed Announces Participation in the Citi Healthcare Conference
SAN DIEGO, Feb. 16, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Citi Healthcare Conference on Wednesday, February 23, 2022, beginning at approximately 12:30 p.m. (Eastern Standard Time) via webcast.
More information about this event, including access to the live webcast, may be accessed by visiting https://investor.resmed.com. The webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible through February 23, 2023.
About ResMedAt ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors | For media | ||
| Amy Wakeham | Jayme Rubenstein | ||
| +1 858.836.5000 | +1 858.836.6798 | ||
| [email protected] | [email protected] |
Source: ResMed Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MISSION SUCCESS: Rocket Lab Launches 97th Electron Mission
- STEMREGEN® Named to Inc. 5000 for Third Consecutive Year
- Florida DTF Transfer Printer Launches Heat Press Kits After Customer Reviews Show New Press Owners Unsure What to Buy Next
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share